This drug is a 4-aminoquinoline compound with anti-inflammatory properties. Under the exemplary leadership and guidance of our expert professionals, we have been able to emerge as a trusted organization engaged in offering Amodiaquine Hydrochloride. The drug is used for treatment of acute malarial attacks in non-immune subjects. It is used as both an antimalarial and an anti-inflammatory agent. Amodiaquine Hydrochloride binds the free heme preventing the parasite from converting it to a form less toxic. The drug depresses cardiac muscle, impairs cardiac conductivity and produces vasodilatation with resultant hypotension.